DK2696844T3 - Forbindelser, der aktiverer peptidylarginindeiminase 1 og/eller 3 i epidermis og anvendelser deraf - Google Patents

Forbindelser, der aktiverer peptidylarginindeiminase 1 og/eller 3 i epidermis og anvendelser deraf Download PDF

Info

Publication number
DK2696844T3
DK2696844T3 DK12713160.5T DK12713160T DK2696844T3 DK 2696844 T3 DK2696844 T3 DK 2696844T3 DK 12713160 T DK12713160 T DK 12713160T DK 2696844 T3 DK2696844 T3 DK 2696844T3
Authority
DK
Denmark
Prior art keywords
epidermis
activate
compounds
peptidylarginine deiminase
peptidylarginine
Prior art date
Application number
DK12713160.5T
Other languages
English (en)
Inventor
Hélène Duplan
Sylvie Daunes-Marion
Stéphane Poigny
Marie-Claire Mechin
Guy Serre
Michel Simon
Original Assignee
Fabre Pierre Dermo Cosmetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabre Pierre Dermo Cosmetique filed Critical Fabre Pierre Dermo Cosmetique
Application granted granted Critical
Publication of DK2696844T3 publication Critical patent/DK2696844T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK12713160.5T 2011-04-11 2012-04-11 Forbindelser, der aktiverer peptidylarginindeiminase 1 og/eller 3 i epidermis og anvendelser deraf DK2696844T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1153135A FR2973704B1 (fr) 2011-04-11 2011-04-11 Composes activateurs des peptidyl-arginine desiminases 1 et/ou 3 dans l'epiderme et leurs utilisations
PCT/EP2012/056596 WO2012140095A1 (fr) 2011-04-11 2012-04-11 Composes activateurs des peptidyl-arginine desiminases 1 et/ou 3 dans l'epiderme et leurs utilisations

Publications (1)

Publication Number Publication Date
DK2696844T3 true DK2696844T3 (da) 2020-02-24

Family

ID=45937377

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12713160.5T DK2696844T3 (da) 2011-04-11 2012-04-11 Forbindelser, der aktiverer peptidylarginindeiminase 1 og/eller 3 i epidermis og anvendelser deraf

Country Status (13)

Country Link
US (1) US9566222B2 (da)
EP (1) EP2696844B1 (da)
JP (1) JP6049691B2 (da)
KR (1) KR101986979B1 (da)
CN (2) CN103561715A (da)
BR (1) BR112013026192B1 (da)
CA (1) CA2832686C (da)
DK (1) DK2696844T3 (da)
ES (1) ES2770433T3 (da)
FR (1) FR2973704B1 (da)
PL (1) PL2696844T3 (da)
PT (1) PT2696844T (da)
WO (1) WO2012140095A1 (da)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8517300D0 (en) * 1985-07-09 1985-08-14 Salim A S M Biologically active substances
JPH0692290B2 (ja) * 1986-02-18 1994-11-16 鐘紡株式会社 皮膚化粧料
FR2639541B1 (fr) 1988-11-29 1993-09-24 Fabre Pierre Cosmetique Amincissants topiques contenant des derives cafeines carboxyliques neutralises par des bases organiques et preparations utiles dans le traitement de la cellulite
JPH08291018A (ja) * 1995-04-18 1996-11-05 Kanebo Ltd 化粧品用保湿剤
JP3488573B2 (ja) * 1996-06-03 2004-01-19 カネボウ株式会社 ボディ用化粧料の製造方法
US6861062B2 (en) * 2000-03-01 2005-03-01 Victor Silva Skin cream
FR2813187B1 (fr) * 2000-08-22 2003-01-17 Oreal Composition, notamment cosmetique, comprenant une sapogenine et une base xanthique
KR100560092B1 (ko) * 2000-12-15 2006-03-10 파트릭 프랑케 저알레르기성 및 비자극성 피부 보호 제제
FR2839449B1 (fr) * 2002-05-13 2006-12-08 Oreal Utilisation d'au moins un complexe de metal comme desquamant
CA2504379A1 (en) * 2002-10-31 2004-05-21 Eric F. Bernstein Compositions and methods for prevention of photoaging
WO2004110396A1 (de) * 2003-06-17 2004-12-23 Dsm Ip Assets B.V. Topisches mittel enthaltend phytansäure oder ein derivat davon
JP2005314367A (ja) * 2004-03-31 2005-11-10 Taisho Pharmaceut Co Ltd 保湿剤組成物
JP2006213696A (ja) * 2005-01-07 2006-08-17 Rohto Pharmaceut Co Ltd 皮膚外用剤
DE102005007468A1 (de) * 2005-02-16 2006-08-31 Beiersdorf Ag Kovalent gebundene Wirkkomplexe, aus denen Stress-aktivierbare Hautenzyme einen Wirkstoff freisetzen
JP2009500394A (ja) * 2005-07-08 2009-01-08 ザ プロクター アンド ギャンブル カンパニー パーソナルケア組成物及び哺乳類の皮膚と毛髪を美化する方法
KR100659138B1 (ko) * 2005-09-16 2006-12-19 (주)아모레퍼시픽 유효성분으로 갈로카테킨 갈레이트를 함유하는 보습용피부외용제 조성물
WO2010019450A2 (en) * 2008-08-09 2010-02-18 Nyles Bauer Synergizing active compounds for treating inflammation and other conditions

Also Published As

Publication number Publication date
FR2973704B1 (fr) 2014-09-05
EP2696844A1 (fr) 2014-02-19
JP6049691B2 (ja) 2016-12-21
EP2696844B1 (fr) 2019-11-13
WO2012140095A1 (fr) 2012-10-18
ES2770433T3 (es) 2020-07-01
CN107320351A (zh) 2017-11-07
KR101986979B1 (ko) 2019-06-07
US20140030200A1 (en) 2014-01-30
FR2973704A1 (fr) 2012-10-12
BR112013026192B1 (pt) 2018-07-31
CN103561715A (zh) 2014-02-05
BR112013026192A2 (pt) 2016-08-23
PT2696844T (pt) 2020-02-21
JP2014510773A (ja) 2014-05-01
CA2832686C (fr) 2020-08-11
KR20140038401A (ko) 2014-03-28
CA2832686A1 (fr) 2012-10-18
US9566222B2 (en) 2017-02-14
PL2696844T3 (pl) 2020-05-18

Similar Documents

Publication Publication Date Title
NO2023021I1 (no) Loncastuximab tesirine in all forms protected by the basic patent
BR112012032969A2 (pt) tiras de fenda e gancho e laminados e artigos contendo as mesmas
DK3425018T3 (da) Kølemiddelblandinger omfattende tetrafluorpropen, difluormethan, pentafluorethan og tetrafluorethan og anvendelser deraf
SMT201600050B (it) Mezzi e metodi per trattare il dlbcl
DK2935303T3 (da) 4`-fluornukleosider, 4`-fluornukleotider og analoger dertil til behandling af HCV
CO6791606A2 (es) Composiciones y métodos para el tratamiento en aplicaciones clínicas de amplio espectro, no diferenciadas o combinadas
BR112014017749A2 (pt) Composto alquinilbenzeno 3,5-dissubstituído e sal do mesmo
EP2867276A4 (en) POLYIMIDE AND POLYIMIDE FILM COMPRISING THE SAME
BR112015001838A2 (pt) composições de inibidor de efluxo e métodos de tratamento utilizando o mesmo.
FR3000095B1 (fr) Composition comprenant du 2,3,3,3-tetrafluoropropene et du 1,2-difluoroethylene
BR112013016299A2 (pt) artigo abrasivo; e método para formar o mesmo
HK1193100A1 (zh) 苯基- -氮雜-雙環 己- -基-甲酮及其作為藥物的用途
DK2825181T3 (da) Porøse carbonpartikler til anvendelse i behandling eller forebyggelse af leversygdom
EP2869824C0 (en) 2-DEOXYGLUCOSE FOR USE IN THE TREATMENT OF AUTOSOMAL DOMINATE POLYCYSTIC KIDNEY DISEASE OR POLYCYSTIC LIVER DISEASE
FR2989319B1 (fr) Vitrage presentant des moyens d'obscurcissement.
IT1403718B1 (it) Magazzino per lo stoccaggio di pezzi allungati in legno, e centro di lavoro comprendente detto magazzino
DK2616709T3 (da) Forbedringer i eller relateret til fastspændingselementer og fastspændingsindretninger.
DK2914286T3 (da) Hidtil ukendte immunterapeutiske molekyler og anvendelser deraf
DK2736936T3 (da) Blokerede præpolymerer og acrylplastisolsammensætninger, der omfatter de blokerede præpolymerer
DK2696844T3 (da) Forbindelser, der aktiverer peptidylarginindeiminase 1 og/eller 3 i epidermis og anvendelser deraf
PL2699545T3 (pl) Nowe pochodne aminopirolinowe, ich zastosowanie w zapobieganiu i/lub leczeniu zespołu metabolicznego
HK1211055A1 (en) New cell-specifically active nucleotide molecules and application kit for the application thereof
BR302012005912S1 (pt) " configuração aplicada em suporte "
SG2012073920A (en) Notebook organiser or the like
ES1077239Y (es) Bloque puerta-cerco reversible y extensible.